25 May 2013
Keywords: new, prepandrix, data, gsk, uk, drug, major
Article | 22 September 2008
UK drug major GlaxoSmithKline presented new data on its Prepandrix H5N1 vaccine at the European Influenza Conference in Vilamoura, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 September 2008
24 May 2013
© 2013 thepharmaletter.com